Cargando…
Emerging Trends in Immunotherapy for Adult Sarcomas
Soft-tissue sarcomas (STS) are a rare and heterogeneous group of malignant tumors that arise from the oncogenic transformation of mesenchymal tissue. There are over 100 distinct STS histological and molecular subtypes with unique clinical, therapeutic, and prognostic features with variable responses...
Autores principales: | Husain, Marium, Chen, Luxi, Liebner, David, Beane, Joal, Rubinstein, Mark, Pollock, Raphael, Verschraegen, Claire, Tinoco, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166169/ https://www.ncbi.nlm.nih.gov/pubmed/36905579 http://dx.doi.org/10.1093/oncolo/oyad052 |
Ejemplares similares
-
Clinical markers of immunotherapy outcomes in advanced sarcoma
por: Husain, Marium, et al.
Publicado: (2023) -
Atrial Thrombus Mimicking Ewing's Sarcoma
por: Hon, Matthew, et al.
Publicado: (2019) -
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID‐19 Pandemic
por: Martin‐Broto, Javier, et al.
Publicado: (2020) -
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma
por: Massoth, Lucas R., et al.
Publicado: (2021) -
Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?
por: George, A, et al.
Publicado: (2012)